NEW
Stock Screener with Intrinsic Value
Protagonist Therapeutics, Inc. (PTGX)
Last Price$37.2(1.6%)
Market Cap$2,297.8M
N/A
Industry median - 13.2%
5Y Historical average - 2,986.0%
N/A
Industry median - 1.0%
5Y Historical average - 27.9%
N/A
Industry median - (20.2%)
5Y Historical average - 5.2%
N/A
Industry median - (1.2%)
5Y Historical average - 25.0%
PTGX Growth Rating
Crunching data... Almost there!
PTGX Growth Metrics
Crunching data... Almost there!
Competing with PTGX Growth
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Protagonist Therapeutics, Inc. (PTGX) revenue growth?
The Protagonist Therapeutics, Inc. (PTGX) revenue growth is N/A, which is lower than the industry median of 13.2% and the 5-year historical average of 2,986.0%.
What is the Protagonist Therapeutics, Inc. (PTGX) operating income growth?
The Protagonist Therapeutics, Inc. (PTGX) operating income growth is N/A, compared to the industry median of 1.0% and the 5-year historical average of 27.9%.
What is the Protagonist Therapeutics, Inc. (PTGX) EPS (Earnings Per Share) growth?
The Protagonist Therapeutics, Inc. (PTGX) EPS growth is N/A, compared to the industry median of (20.2%) and the 5-year historical average of 5.2%.
What is the Protagonist Therapeutics, Inc. (PTGX) Free Cash Flow (FCF) growth?
The Protagonist Therapeutics, Inc. (PTGX) Free Cash Flow growth is N/A, compared to the industry median of (1.2%) and the 5-year historical average of 25.0%.